Essential Thrombocythemia
Showing NaN - NaN of 7
Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Decitabine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 18, 2022
Essential Thrombocythemia Trial in Worldwide (IMG-7289)
Active, not recruiting
- Essential Thrombocythemia
-
Jacksonville, Florida
- +25 more
Apr 15, 2022
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- +13 more
- Cyclosporine
- +6 more
-
Salt Lake City, Utah
- +2 more
Jan 15, 2020
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +178 more
- fludarabine phosphate
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +22 more
- therapeutic allogeneic lymphocytes
- +10 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Mar 27, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014